These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparative lymphatic, ocular, and metabolic phenotypes of Foxc2 haploinsufficient and aP2-FOXC2 transgenic mice. Noon A, Hunter RJ, Witte MH, Kriederman B, Bernas M, Rennels M, Percy D, Enerbäck S, Erickson RP. Lymphology; 2006 Jun; 39(2):84-94. PubMed ID: 16910099 [Abstract] [Full Text] [Related]
3. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Kriederman BM, Myloyde TL, Witte MH, Dagenais SL, Witte CL, Rennels M, Bernas MJ, Lynch MT, Erickson RP, Caulder MS, Miura N, Jackson D, Brooks BP, Glover TW. Hum Mol Genet; 2003 May 15; 12(10):1179-85. PubMed ID: 12719382 [Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Nat Immunol; 2004 Jan 15; 5(1):74-80. PubMed ID: 14634646 [Abstract] [Full Text] [Related]
6. Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Dagenais SL, Hartsough RL, Erickson RP, Witte MH, Butler MG, Glover TW. Gene Expr Patterns; 2004 Oct 15; 4(6):611-9. PubMed ID: 15465483 [Abstract] [Full Text] [Related]
7. Clinical and genetic study of 46 Italian patients with primary lymphedema. Michelini S, Degiorgio D, Cestari M, Corda D, Ricci M, Cardone M, Mander A, Famoso L, Contini E, Serrani R, Pinelli L, Cecchin S, Bertelli M. Lymphology; 2012 Mar 15; 45(1):3-12. PubMed ID: 22768468 [Abstract] [Full Text] [Related]
9. Abnormal mural cell recruitment in lymphatic capillaries: a common pathological feature in chronic lymphedematous skin? Yu ZY, Sun D, Luo Y, Liu NF. Microcirculation; 2016 Oct 15; 23(7):495-502. PubMed ID: 27455448 [Abstract] [Full Text] [Related]
10. H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice. Ichise T, Yoshida N, Ichise H. Development; 2010 Mar 15; 137(6):1003-13. PubMed ID: 20179099 [Abstract] [Full Text] [Related]
15. Combining Foxc2 and Connexin37 deletions in mice leads to severe defects in lymphatic vascular growth and remodeling. Kanady JD, Munger SJ, Witte MH, Simon AM. Dev Biol; 2015 Sep 01; 405(1):33-46. PubMed ID: 26079578 [Abstract] [Full Text] [Related]
19. Lymphatic endothelial cells, lymphedematous lymphangiogenesis, and molecular control of edema formation. Ji RC. Lymphat Res Biol; 2008 Nov 01; 6(3-4):123-37. PubMed ID: 19093784 [Abstract] [Full Text] [Related]
20. Targeted treatment for lymphedema and lymphatic metastasis. Tervala T, Suominen E, Saaristo A. Ann N Y Acad Sci; 2008 Nov 01; 1131():215-24. PubMed ID: 18519974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]